Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency ...

ChREBP is a transcription factor that plays a crucial role in regulating glucose metabolism. It exists in two main isoforms: ChREBPα and ChREBPβ. This is the first study to identify and develop small ...

Mount Sinai scientists will continue studying PGV001 in larger groups of patients and testing how it works with other cancer treatments. Data from this phase 1 study have prompted three additional ...

A team of researchers has made a breakthrough in diabetes treatment, uncovering a way to regenerate human insulin-producing beta cells. Their discovery, published in Science Translational Medicine, ...

Researchers at the Icahn School of Medicine at Mount Sinai have made an important discovery that could help doctors choose better treatments for patients with recurrent endometrial cancer.

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new genetic interactions that may contribute ...

A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...

Researchers at the Icahn School of Medicine at Mount Sinai have developed a powerful ... potentially accelerating the discovery of new treatments for a wide range of diseases," Dr. Zhang added.

Advancing Drug Discovery Through Computational Approaches ... Research Professor of Neurogenetics and Director of the Mount Sinai Center for Transformative Disease Modeling.

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, PhD, Ward-Coleman Chair in Cancer ...